Whey protein and glycaemia in adults with poor glucose control_V1

  • Research type

    Research Study

  • Full title

    The impact of whey protein on fasting and postprandial glycaemia in adults with poor glucose control

  • IRAS ID

    239941

  • Contact name

    Julie Lovegrove

  • Contact email

    j.a.lovegrove@reading.ac.uk

  • Sponsor organisation

    University of Reading

  • Duration of Study in the UK

    2 years, 0 months, 0 days

  • Research summary

    In the UK, more than 700 people are diagnosed with type 2 diabetes each day, which has significant cost effects for the NHS of approximately £10 billion each year for the treatment of diabetes and its complications. The primary treatment for type 2 diabetes is dietary and lifestyle changes, however there is still considerable uncertainty about the best dietary strategies to reduce blood glucose levels and improve glucose control. The existing scientific evidence suggests an important role of milk and dairy products and especially of whey protein in the control of blood glucose levels.

    This study is designed to determine if 50 g of whey protein is consumed every day in the diet, for 8 weeks, will result in a better fasting blood glucose control compared with 50 g of wheat protein and 50 g of wheat protein containing a similar amount of leucine as the whey protein. In this double-blind (both the researcher and the participant will not know the type of protein that has to be consumed during each study arm, controlled cross-over dietary intervention study, 48 people (24 men and 24 women), aged 20-65 years with poor fasting glucose control will receive 3 different protein supplements in random order for 8 weeks, with a 4-week wash-out period between each protein supplement. At the beginning and end of each protein phase, a fasting blood sample will be collected to evaluate the long-term effects of the specific protein on fasting blood glucose control, endothelial function (blood vessel health), markers of insulin sensitivity and other cardio metabolic risk markers.
    At the end of each protein intervention phase, a subgroup of participants (28) will also take part in a day-long (postprandial) study visit to assess the effects of the assigned protein powders on short-term changes in blood sugar control.

  • REC name

    South Central - Hampshire A Research Ethics Committee

  • REC reference

    18/SC/0140

  • Date of REC Opinion

    20 Mar 2018

  • REC opinion

    Unfavourable Opinion